Analysis of the signal cross talk via CCL26 in the tumor microenvironment in osteosarcoma.
Analysis of the signal cross talk via CCL26 in the tumor microenvironment in osteosarcoma.
批准号:
18K16666
负责人:
Iwasaki Tatsuya
金额:
$2.66万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Early-Career Scientists
财政年份:
2018
资助国家:
日本
项目状态:
已结题
起止时间:
2018-04-01 至 2020-03-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Surrogacy of intermediate endpoints for overall survival in randomized controlled trials of first-line treatment for advanced soft tissue sarcoma in the pre- and post-pazopanib era: a meta-analytic evaluation.
帕唑帕尼时代前后晚期软组织肉瘤一线治疗的随机对照试验中总生存期的中间终点替代:荟萃分析评估。
DOI:
10.1186/s12885-019-5268-2
发表时间:
2019
期刊:
BMC Cancer.
影响因子:
--
作者:
[Tanaka K, Kawano M, Iwasaki T, Itonaga I, Tsumura H.]
通讯作者:
Tsumura H.
The antitumor effect of 17-DMAG combined with Doxorubicin in osteosarcoma cells.
-
批准号:16K20063
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.5万
-
财政年份:2016
-
负责人:Iwasaki Tatsuya
-
依托单位:
海外基金